Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie / Febbraio 2019

Archivio

✕

28 febbraio 2019

8838

Experts: use of PrEP in Scotland is significantly higher than forecast

Experts: use of PrEP in Scotland is significantly higher than forecast

According to the latest data, in Scotland today over 1.8 thousand people take the drug "Truvada" as a pre-exposure prophylaxis of HIV (PrEP). The country was the first part of Britain, which in July 2017 made DCT available for NHS purchases for free distribution to risk ...

26 febbraio 2019

7518

Italian teenagers will be able to take an HIV test without parental consent

Italian teenagers will be able to take an HIV test without parental consent

Italian citizens who have not reached the age of majority will be able to get tested for HIV without parental approval, the Adnkronos portal reported on Tuesday, citing the country's health minister, Julia Grillo.

24 febbraio 2019

8101

Scientists: HIV medication will help people recovering from a stroke

Scientists: HIV medication will help people recovering from a stroke

The most serious problem associated with the rehabilitation of people after a stroke remains the loss of part of their functions by the brain. As numerous studies have shown, so far none of the tools directly affected the restoration of lost neural connections. However, ...

23 febbraio 2019

7356

Cancer immunotherapy effectively fights HIV reservoirs

Cancer immunotherapy effectively fights HIV reservoirs

A team of specialists from the University of Montreal Hospital Research Center (CRCHUM) showed that cancer immunotherapy can reduce the HIV level in the body PLHIV if the latter are taking triple therapy. Scientists have determined how this treatment method can detect the ...

22 febbraio 2019

7381

Only 40% of Americans do not quit PrEP for two years

Only 40% of Americans do not quit PrEP for two years

According to Walgreens, the largest pharmacy network in the United States, only two out of five people continue to receive pre-exposure prophylaxis HIV (PrEP) two years after the start. The analysis was published this week in the AIDS Society.

21 febbraio 2019

7102

HIV prevention and effective care reduces infection among transgender women

HIV prevention and effective care reduces infection among transgender women

Prevention programs for HIV among transgender women can reduce the spread of the virus, according to the results of an analysis published in the beginning of February in the journal Sexually Transmitted Diseases. However, according to experts, in order to increase the effectiveness ...

20 febbraio 2019

7731

New look at widely neutralizing antibodies can improve HIV vaccine design

New look at widely neutralizing antibodies can improve HIV vaccine design

A new study conducted by specialists at Duke University Medical Center (USA), drew attention to the importance of studying the previously unaffected bnAb mutations, which occur in the early stages and give antibodies the flexibility to adapt to changes in the structure of ...

18 febbraio 2019

7548

Cannabis smoking is an independent risk factor for lung disease in people with HIV

Cannabis smoking is an independent risk factor for lung disease in people with HIV

According to a study by a group of scientists from the United States, frequent smoking of cannabis is a risk factor for lung disease in men living with HIV. It increases the likelihood of disease, especially in cases where there is an infectious cause, and does not depend ...

17 febbraio 2019

8474

EMA approved two new doravirin-based ARV drugs

EMA approved two new doravirin-based ARV drugs

The European Medicines Agency (EMA) has approved the use of drugs for the treatment of HIV Delstrigo and Pifeltro. As previously reported, FDA granted permission for their marketing in the United States at the end of August last year.

16 febbraio 2019

6828

First evidence of the presence of HIV reservoirs in macrophages

First evidence of the presence of HIV reservoirs in macrophages

Scientists from France recently discovered that macrophages located in the tissue of the urethra may play a much more significant role in the work of HIV cell reservoirs, and that the number of these immune cells is surprisingly large. The results were published last week ...

1 2